Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Auxly Cannabis Group Inc T.XLY

Alternate Symbol(s):  CBWTF

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company also conducts wholesale bulk sales of dried cannabis to various licensed producers in Canada. Its subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., and Auxly Leamington Inc. The Company’s primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing and conducts the Company’s primary dried flower and pre-roll manufacturing.


TSX:XLY - Post by User

Bullboard Posts
Comment by Fundy13on Feb 25, 2019 11:26am
57 Views
Post# 29409072

RE:RE:RE:RE:RE:RE:Auxly valued at $4 - $7 if you read article

RE:RE:RE:RE:RE:RE:Auxly valued at $4 - $7 if you read articleAnd if that is how you feel then you are entitle to that opinon.
I think most of what XLY has told its investors has happened so far and the things that have not happened like the FSD pharma deal, have been because of unknown circumstances not dishonesty.
I think a lot of the misconception around things changes comes from the fact that the industry adopted a standard of reporting funded capacity.  When they first started reporting possible production it was based on full expantion of all projects even those that were not started or funded, which was standard pratice at the time.  Now they are only reporting capacity that is fully funded.  For Example FSD had plans for a phase 2 and phase three.  only phase 2 that had started being built and XLY had the money in the bank to fund would have been included in funded capacity, previosly they would have also included the Phase three expanstion in the numbers which would have added a couple hundread thousand KGS.  I think funded capacity is a good way for things to be reported.
Based on funded capacity XLY ranks 4th only behind WEED, ACB and APH.  That is not a number that can really be manipulated as it is based on known consrtuction, that has already started and if fully funded.
IO do not think XLY should be the 4th most valuble company because of that because several companies that have less funded capacity have either more proven distribution then XLY like OGI for example or a large well know US companies investment, HEXO for example.  But I do think they should be in the top 10 for Market Cap and they are not even there.
Bullboard Posts